| Literature DB >> 35898823 |
Kenta Ishimoto1,2, Koichiro Yoshimaru1, Yasuyuki Uchida1, Keisuke Kajihara1, Satoshi Obata1, Toshiharu Matsuura1, Tatsuro Tajiri1.
Abstract
Gastrointestinal bleeding or perforation following influenza infection is rare. We encountered a pediatric case of hemorrhagic duodenal ulcer following influenza A infection. The patient was a 1-year and 4-month-old boy who was diagnosed with influenza A infection and treated with laninamivir octanoate. After inhalation, he had diarrhea, poor appetite, and melena. The next day, he had hematochezia and developed hemorrhagic shock. Contrast-enhanced computed tomography showed extravasation in the descending part of the duodenum. Esophagogastroduodenoscopy revealed spurting bleeding from a Dieulafoy's lesion on the oral side of the major papilla, and he underwent hemostasis by clipping. From the bulb to the descending part of the duodenum, the mucosa appeared atrophic with spotty redness on the circular folds and multiple and irregularly shaped erosions. Almost all mucosal lesions had healed by the eighth day, and he was monitored as an outpatient for more than one year without re-bleeding. Intestinal ischemia, viral invasion, and drug reaction of laninamivir octanoate may be involved in duodenal mucosal injury. Acute duodenal ulcers may occur in children with influenza infection, especially young children.Entities:
Keywords: children; duodenal ulcer; hemorrhaging; influenza; laninamivir octanoate
Year: 2022 PMID: 35898823 PMCID: PMC9307743 DOI: 10.1002/deo2.155
Source DB: PubMed Journal: DEN open ISSN: 2692-4609
FIGURE 1Abdominal contrast‐enhanced computed tomography showing extravasation in the descending part of the duodenum, and the mildly thickened and unevenly enhanced wall of the bulb to the descending part. (a) Axial view. (b, c) Coronal view. Arrows indicate contrast extravasation. Black arrowheads indicate the thickened and weakly enhanced wall and white arrowheads indicate the thickened and strongly enhanced wall
FIGURE 2(a, b) Esophagogastroduodenoscopy showing spurting bleeding from an exposed blood vessel (arrowhead) on the oral side of the major papilla. (c) Hemostasis was obtained by clipping. (d) From the bulb to the descending part of the duodenum, the mucosa appeared to be atrophic, and there was spotty redness on the circular folds and multiple irregularly shaped erosions
FIGURE 3Esophagogastroduodenoscopy on day 8 showed that the duodenal mucosa had healed, with no erosion or redness remaining, except for that caused by contact, and granulation had formed at the clipping site. (a) The bulb. (b) From the superior duodenal angle to the clipping site. (c, d) The descending part, including the clipping site
Previously reported cases of duodenal bleeding or perforation in children with influenza infection
| Gastrointestinal symptoms | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. | Year | Author | Age/sex | Diagnosis | Locations | Treatments | Type of virus | Drugs | Onset | Symptoms |
| 1 | 2012 | Watanabe E et al. | 2/M | Hemorrhaging | Bulb | Endoscopy →transcatheter arterial embolization | Unknown | Unknown | Unknown | Melena and abdominal pain |
| 2 | 2013 | Hsueh CW et al. | 14/F | Perforation | Unknown | Laparotomy | A | Oseltamivir | Fourth day after administration of the drug | Abdominal pain and vomiting |
| 3 | 2016 | Park CW et al. | 4/F | Hemorrhaging (Henoch‐Schönlein purpura) | Bulb | Steroid therapy | Unknown | Oseltamivir | Details unknown after administration of the drug | Abdominal pain and vomiting |
| 4 | 2018 | Masui M et al. | 1/M | Hemorrhaging | Bulb (posterior wall) | Endoscopic clipping | A | Oseltamivir | Second day after administration of the drug | Vomiting |
| 5 | 2018 | Masui M et al. | 4/M | Hemorrhaging | Bulb (posterior wall) | Endoscopy → laparotomy | A | Oseltamivir | Same day after administration of the drug | Abdominal pain and vomiting |
| 6 | 2022 | Our case | 1/M | Hemorrhaging | Bulb and descending part | Endoscopic clipping | A | Laninamivir octanoate | Same day after administration of the drug | Diarrhea, poor appetite and vomiting |